The guideline lays out the optimal strategies for the treatment of opioid addiction and recommends opioid agonist treatment with buprenorphine-naloxone as the preferred first-line treatment.
National Guideline for the Clinical Management of Opioid Use Disorder - CRISM
Previous
Previous
Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome
Next
Next